Picture of Cannasouth logo

CBD Cannasouth Share Price

0.000.00%
nz flag iconLast trade - 00:00
HealthcareAdventurousMicro Cap

Momentum

Relative Strength (%)
1m-15.65%
3m-26.49%
6m-55.27%
1yr-68.22%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-69.38%
50d MA-16.85%
200d MA-44.47%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-16.3%
Return on Equity-29.26%
Operating Margin-899.28%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Cannasouth EPS forecast chart

Profile Summary

Cannasouth Limited is a New Zealand-based biopharmaceutical company focused on medicinal cannabis. The Company is vertically integrated, with business activities ranging from the production and supply of cannabis flower, manufacturing of cannabis-based ingredients and finished dosage products. It also offers an online clinic, and related activities, such as research and development, marketing, and sales. The Company provides a range of imported, Cannasouth-branded medicinal cannabis products. Its subsidiaries include Eqalis Pharmaceuticals Limited, Eqalis Innovation Limited, Cannasouth Bioscience Limited, and Cannasouth Cultivation Limited.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    August 21st, 2018
    Public Since
    June 19th, 2019
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    nz flag iconNew Zealand Stock Exchange
    Shares in Issue
    330,470,590

    CBD Share Price Performance

    Upcoming Events for CBD

    Cannasouth Ltd Annual Shareholders Meeting

    Half Year 2024 Cannasouth Ltd Earnings Release

    Similar to CBD

    Picture of Pacific Edge logo

    Pacific Edge

    nz flag iconNew Zealand Stock Exchange

    FAQ